The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study
- 8 November 2000
- journal article
- Published by Elsevier in Brain Research
- Vol. 883 (2) , 216-223
- https://doi.org/10.1016/s0006-8993(00)02929-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Pramipexole Reduces Reactive Oxygen Species Production In Vivo and In Vitro and Inhibits the Mitochondrial Permeability Transition Produced by the Parkinsonian Neurotoxin Methylpyridinium IonJournal of Neurochemistry, 1998
- Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia NigraJournal of Neurochemistry, 1997
- A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body DiseaseJournal of Neurochemistry, 1997
- Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeysEuropean Journal of Pharmacology, 1997
- Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexoleJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Effect of piribedil, a D-2 dopaminergic agonist, on dopamine, amino acids, and free radicals in gerbil brain after cerebral ischemiaMolecular and Chemical Neuropathology, 1995
- Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivoEuropean Journal of Pharmacology, 1991
- Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's DiseaseJournal of Neurochemistry, 1989
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960